Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F6U4J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,698
Award facts
- Contract value 100% obligated
- $10,697.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,697.55 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens (2 mL) under a firm fixed-price contract. The award, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, carries no set-aside designation and was competitively awarded. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. Dupixent is a specialty pharmaceutical product used in treating atopic conditions, aligning with the company's extensive portfolio of brand-name medications, generic drugs, and medical supplies delivered across multiple therapeutic domains. The DLA procures pharmaceutical commodities through AmerisourceBergen to support Defense Health Agency operations, U.S. Coast Guard medical needs, and other government healthcare systems, with the broader SPE2DX contract encompassing vaccines, syringes, vials, test kits, and specialty medications to support military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26F6U4J?
SPE2DR26F6U4J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26F6U4J worth?
The government has obligated $10,698 on SPE2DR26F6U4J.
Is contract SPE2DR26F6U4J an order under another contract?
Yes. SPE2DR26F6U4J is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6U4J competed?
The extent of competition for SPE2DR26F6U4J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award